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Introduction
Hepatic fibrosis is indicated by an accumulation of
connective tissue molecules, mainly collagen, in
the extracellular matrix. The etiology of fibrosis in-
cludes chronic injuries of various types. Advanced
fibrosis develops into hepatic cirrhosis, which is an
irreversible process with profound changes in the
organ architecture (Wasmuth and Weiskirchen,
2010). Since liver fibrosis is potentially reversible,
markers for its detection are essential to identify
any early alterations in the liver tissue. Besides
connective tissue staining like Masson trichrome
stain, immunohistochemistry markers could also be
of interest as they are useful in detecting molecular
changes and cell activation during the fibrotic
process. This may make an early diagnosis possi-
ble. 
In order to establish novel immunohistochem-
istry markers for liver fibrosis it is important to
consider the pathogenesis of liver fibrosis. Hepatic
fibrosis is induced by chronic stimuli, which acti-
vate Ito cells in the peri-sinusoidal space. Under
physiological conditions Ito cells serve as storage
cells for fat and vitamin A and are found in the sub-
sinusoidal space along the sinusoid. The activation
occurs mainly due to necrobiotic hepatocytes and
activated Kupffer cells. After cytokine induced ac-
tivation, Ito cells proliferate to transform from rest-
ing cells to contractile myofibroblasts (Gressner,
1991, Bachem et al., 1992), which are then in-
volved in the onset of fibrosis. Various cytokines,
including transforming growth factor (TGF) that
are produced in the hepatocytes and Kupffer cells
induce proliferated Ito cells to synthesize extracel-
lular matrix (Houglum et al., 1994). It is known
that, during the fibrotic process, TGF-β1 serum
concentration is markedly increased (Neumann et
al., 2008). A further change during the activation
of Ito cells is their metamorphosis to myofibrob-
lasts (Rockey et al., 1993). Myofibroblasts can
cause a reduction in the sinusoidal blood flow lead-
ing to portal hypertension and contraction of the
liver parenchyma (Pinzani et al., 1992, Marra et al.,
1993). Both of these are typical pathophysiological
features of the end-stage liver cirrhosis. Owing to
their role in the fibrotic and cirrhotic liver diseases,
activated Ito cells are vital cellular structures for
these processes. To chararcterize the remodeling
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Abstract
Liver cirrhosis is a fatal end-stage of various chronic liver diseases. It develops from persistent liver cell necrosis with resulting
fibrosis.  Because liver cirrhosis is an irreversible process it is important to recognize the reversible fibrotic stages of the dis-
ease. Different markers and staining are currently used to detect fibrosis. Besides plasma markers, some tissue markers are
currently being used for this purpose. In this study, we investigated the expression of two immunohistochemical markers
(Ki-67, α-SMA) in liver diseases with and without fibrosis in dogs and compared their expression with the degree of tissue
fibrosis, assessed by Masson trichrome staining. In all the stages of fibrosis, Ki-67 and α-SMA was expressed in the liver tis-
sue. There was no significant difference between Masson trichrome staining which is “gold standard” and expression of Ki-
67 or α-smooth muscle actin (SMA). We concluded that Ki-67 and α-SMA can be potentially used as markers for the fibrotic
remodeling of the liver. 
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process in the liver, markers associated with the
proliferation and metamorphosis of Ito cells could
be of interest. Two such potential markers are Ki-
67 and α-smooth muscle actin (α-SMA).  
Ki-67 is a protein that is expressed during cell
proliferation and can be found during all the stages
of cell cycle except the G0 phase. It is described to
be present in cells of different organs during cell
proliferation (Scholzen and Gerdes, 2000). In liver,
it is also found in the hepatocytes during neoplastic
proliferation (Neumann and Kaup, 2005). α-
smooth muscle actin (α-SMA) is an important pro-
tein, which is synthesized during Ito cell activation
and transformation into myofibroblasts and is used
as a marker for this process in humans (Akpolat et
al., 2005).
In order to confirm the use of α-SMA in dogs
and investigate further markers for Ito cell activa-
tion we analyzed the expression of both α-SMA
and Ki-67 in fibrotic liver tissue of dogs. The aim
of this study was to investigate the expression of a
metamorphoric marker (α-SMA) and a prolifera-
tion marker (Ki-67), to further elucidate the tissue
alteration process during the fibrotic process and
to establish new markers for fibrosis.
Materials and methods
Animals
Twenty-two dogs who were patients at the Clinic
for Small Animals, University of Gottingen, Ger-
many, were included in this study. The diagnosis of
liver disease was based on histopathological exam-
ination of the biopsies. Liver biopsies were per-
formed under the ultrasound guidance or by
laparotomy. Three to four biopsy specimens were
taken. During laparotomy, biopsy specimens were
taken from the macroscopically altered tissue. In
the case of ultrasound guidance, the samples were
taken from ultrasonographically altered tissue. We
used a True-Cut biopsy needle (Surgi-Vet) for tak-
ing the biopsy specimens under ultrasound guid-
ance. Each specimen was approximately 2 mm in
thickness and 2 cm in length.
Histology and Immunohistochemistry
Specimens
For diagnosis, the biopsies were fixed in 10% for-
malin solution stained with hematoxylin-eosin and
Masson trichrome stain and were investigated by
an experienced pathologist. One part of the biopsy
was prepared for immunohistochemistry with Ki-
67 and α-SMA antibodies. On the other, Masson
trichrome staining was performed using standard
protocol (www.medilexicon.com). Briefly, the tis-
sue samples were stained with Mayer's hema-
toxylin, Biebrich scarlet-acid fuchsin and light
green solution. 
Immunohistochemistry
Ki-67
For immunohistochemical detection of Ki-67 ex-
pression the histological sections were placed in a
pressure cooker, which contained 1 l of boiling 10
mM sodium citrate buffer (pH 6.0). After acquiring
maximum pressure, slides were boiled for 1
minute. Pressure equalization was achieved by
cooling with water and slides were replaced after
20 minutes of incubation. Immunohistochemistry
was performed using the automated NexES®-IHC-
staining system (Ventana Medical Systems, Tuc-
son). This system applied a
streptavidin-biotin-peroxidase complex technique
using the primary antibody CONFIRMTM Anti-
Ki67 (Clone K-2) (Cat.790-2910, Ventana Medical
Systems), available in a ready-to-use dilution.
iViewTM detection system (Ventana Medical Sys-
tems), which is an integral part of the NexES®-
IHC-staining system, was used for the visualization
of the primary antibody.
The automated staining procedure was carried
out according to the following steps. First, the
slides were heated to 37°C. Then the I-VIEW In-
hibitorTM containing 3% hydrogen peroxidase was
applied for 4 minutes to inhibit the endogenous per-
oxidase followed by 10 minutes of Option 1TM
(goat serum 1:5, diluted with phosphate buffered
saline) to block unspecific binding sites. The slides
were incubated in CONFIRMTM Anti-Ki67
(Clone K2) for 32 minutes followed by Fixative
1TM (20 μl Glutardialdehyde in 10 ml 0.9% NaCl)
for 2 minutes.
The slides were subsequently incubated for 8
min with a biotin-labelled multi-link secondary an-
tibody (I-VIEW Biotin Ig), which could detect both
mouse and rabbit immunoglobulins. The strepta-
vidin-peroxidase complex (I-VIEW SA-HRP) and
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the chromogenic substrate solution (I-VIEW DAB,
I-VIEW H2O2) were each applied for 8 minutes.
Subsequent to incubation with copper sulphate so-
lution (5g/l, 4 minutes), the slides were counter-
stained with hematoxylin and bluing reagent for 4
minutes each. All steps were followed by incuba-
tion with 10XAPK Wash Solution (Ventana Med-
ical Systems, Cat. 250-042). The slides were
mounted manually and viewed under a Zeiss Ax-
iophot microscope using 10X to 40X magnifica-
tion. Confirmed positive histological sections were
used as positive controls. For negative controls, the
primary antibody incubation was omitted from the
staining protocol.
α-SMA
For anti-SMA staining the slides were treated in a
similar way as described above.The primary anti-
body, Anti-SMA (Dako Cytomation, monoclonal
mouse anti- human, Clone 1A4, Code No. M 0851)
was used at a 1:200 dilution. Ventana’s iViewTM
detection system was applied for the visualization
of the primary antibody using methods identical to
detection of Ki-67 as described in the previous sec-
tion.
The immunoreactivity was assessed semi-quan-
titatively. Further, we divided the 22 patients into
four groups depending on the degree of fibrosis as-
sessed by Masson trichrome staining. The degree
of α-SMA and Ki-67 expression was compared to
the degree of fibrosis within each group.
Results
The results of this study are summarized in Table
1. Three cases were histopathologically diagnosed
with neoplastic liver disease, four with the degen-
erative process and 15 cases with hepatitis. The de-
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Table 1. Histopathology of dogs in this study. Beside the diagnosis, the expression of α-SMA and Ki-67
was assessed semiquantitatively. 0 = no expression; 1 = mild expression; 2 = moderate expression; 3 =
severe expression. The degree of fibrosis was observed using Masson trichrome stain. 0 = no fibrosis; 1
= mild fibrosis; 2 = moderate fibrosis; 3 = severe fibrosis or cirrhosis.
gree of fibrosis was assessed using Masson
trichrome staining. Four dogs in this study showed
no signs of fibrotic process. Eleven dogs had mild
focal interstitial fibrosis and four had moderate fi-
brosis. Finally, three dogs had severe fibrosis or cir-
rhosis. In each dog, Ki-67 and α-SMA
immunohistochemistry were performed. Out of
three cases of severe fibrosis two showed high se-
vere expression of Ki -67 and α-SMA. In one case
mild expression of Ki-67 and moderate expression
of α-SMA was seen. Out of four cases with mod-
erate fibrosis, two cases showed moderate expres-
sion of Ki-67 or α-SMA (Fig. 1-3) whereas two
other cases showed mild expression of Ki-67 or α-
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Fig. 1. Ki-67 positive cells in a case of liver tumor with focal fibrosis
Fig. 2. Α-SMA positive cells in the same case as Fig. 1.
SMA. Among the dogs with mild fibrosis, expres-
sion of Ki-67 and α-SMA was variable ranging
from high to mild levels (Table 1). 
Finally, the cases with no fibrosis also showed
variation in the expression of Ki-67 and α-SMA,
with none to moderate levels of the proteins. The
comparison between Ki-67 and α-SMA showed
complete concordance between the degree of Ki-
67 and α-SMA expression in 12 dogs. In nine dogs,
the difference between the levels of Ki-67 and α-
SMA expression was one degree. In three dogs the
degree of Ki-67 expression was observed to be one
degree more than α-SMA and in six cases the α-
SMA was found to be one degree more than Ki-67.
In one case the difference between the two markers
was two degrees. The degree of fibrosis and the ex-
pression of α-SMA and Ki-67 were compared
using the Mann-Whitney U-Test. No significant
difference was observed between the degree of fi-
brosis and the expression of α-SMA and Ki-67 (P
> 0.05). Unfortunately it was impossible to detect
activated Ito cells with Ki-67 or α-SMA clearly. So
the positive Ki-67 tissue reaction we observed
could be a consequence of activated Kupffer cells
or hepatocytes.
Discussion
Liver fibrosis is a crucial consequence of chronic
liver diseases with different etiology. Epidemiolog-
ical studies have shown that liver fibrosis and end-
stage liver cirrhosis is a common pathological fea-
ture in dogs (Favier, 2009). Due to its reversible
character, it is important to recognize liver fibrosis
since at the stage of fibrosis, therapy can be suc-
cessfully performed (Honeckman, 2003, Povero et
al., 2010). Different investigators have shown that
the characteristics of liver fibrosis change during
disease progression (Gressner, 1991, Thornburg,
1998). Thus, at the beginning, there are only a few
deposits of extracellular matrix, which make a spe-
cific diagnosis difficult. However, by the end-stage,
organ architecture has undergone irreversible
changes and a mixture of fibrotic deposits and re-
generative nodules are present. Markers defining
the fibrotic process are important for assessing the
progression of the disease, to establish a prognosis
and to gain important information that may have
therapeutic implications. The fibrotic process be-
gins with increased deposits of different types of
collagen and proteoglycans (Gressner and Bachem,
1990, Gressner, 1991). Therefore, identification of
these proteins is useful for delineating liver fibro-
sis. Unfortunately, at this time, irreversible fibrotic
changes already begin. Therefore, it is useful to
find a marker that can predict extracellular matrix
production. The pathophysiological process of liver
fibrosis shows that activation of Ito cells is an im-
portant step in the disease progression (Pinzani,
1992). Thus, identification of activated Ito cells
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Fig. 3. Masson trichrome stain in the same case as Fig. 1 and 2.
could be a good marker for the onset of liver fibro-
sis. One marker that is already known is α-SMA
(Otogawa et al., 2009). In this study, we investi-
gated α-SMA and Ki-67 expression in hepatic tis-
sue as potential markers for defining the start of
hepatic fibrosis in dogs. Ki-67 is a nuclear marker
for cellular activation. In our previous study of liver
tumors in dogs, we showed that activation of hepa-
tocytes in neoplastic transformation is identifiable
with Ki-67 (Neumann and Kaup, 2005). In the
present study, we show that liver tissue express Ki-
67 during the activation process of fibrosis. The
same is true for α-SMA, which was also expressed
in the liver tissue. It was impossible to detect acti-
vated Ito cells clearly, but tissue expression of α-
SMA and Ki-67 correlates with the degree of
fibrosis in this study. Therefore, we conclude that,
α-SMA and Ki-67 expression are reliable markers
of  fibrotic transformation of the liver tissue. It is
useful to detect early stages of the disease and can
support diagnosis obtained by standard methods
like Masson trichrome staining. 
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